DNM1L and neurodegenerative disease: Further investigations on how the CAST–calpain–Drp1 cell death pathway is controlled and how the biological optimization of CHIR99021 may accelerate the discovery of therapeutic approaches to treat multiple neurodegenerative diseases are warranted.